StockData
Lumexa Imaging Holdings, Inc. logo

Lumexa Imaging Holdings, Inc. (LMRI) stock

LMRINasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$14.01−0.62 (-4.24%)

Close on Nov 18, 2026Market cap $1.35BP/E –Yield –

Lumexa Imaging revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$271.97M+8.2%
Q2 FY2026Jun 30, 2026$264.16M+7.8%
Q1 FY2026Mar 31, 2026$252.54M–
Q3 FY2025Sep 30, 2025$258.94M–
Q2 FY2025Jun 30, 2025$251.40M–
Q1 FY2025Mar 31, 2025$245.00M–

More Lumexa Imaging figures

See a number that looks wrong?